Correlation of clinical benefit from immune checkpoints and baseline radiomic signature in inoperable NSCLC without activating mutations.

Authors: Fedor Vladimirovich Moiseenko, Marko Radulovic, Nadezhda Tsvetkova, Vera Chernobrivtceva, Albina Gabina, Ani Oganesyan, Ekaterina Elsakova, Elizaveta Artemeva, Valeria Khenshtein, Nikita Volkov, Alexei Bogdanov, Maria Makarkina, Vladimir Moiseyenko

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20571

Source: Full article

---

Abstract

e20571